Who we are
Before founding Vivodiem in 2008, I worked for 27 years in Drug Metabolism and Pharmacokinetics, at G.D. Searle until 1993, then at Eli Lilly until 2007, in Europe and in the United States.
I have an educational background in organic chemistry and in biochemistry, and most particularly in drug metabolism and drug analysis by mass spectrometry.
I have been involved in all DMPK areas:
- early and late phase drug development
- in-vitro and in-vivo drug metabolism
- preclinical and clinical PK
- drug quantification and metabolite structure elucidation
- drug metabolism related toxicity issues
- program teams from various therapeutic areas
- automation of ADME screening and of metabolite identification
- due diligence missions
- research of new partnership and acquisitions
For more information, please download my curriculum vitae here: 